2BB score and signals
Zentalis Pharmaceuticals, Inc.’s current 2BB score is 48 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 66 | High |
| Momentum | 60 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 41 | Moderate |
Company facts
| Founded | 2014 |
| Employees | 106 |
| 52-week range | $1.21 – $6.95 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -0.5939 | — | $0.00 |
| 2026-08-04 | — | -0.4997 | — | $0.00 |
| 2026-05-12 | -0.5 | -0.4861 | $0.00 | $0.00 |
| 2026-03-26 | -0.5 | -0.5906 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish